GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (FRA:6MD) » Definitions » Beneish M-Score

Medacta Group (FRA:6MD) Beneish M-Score : -2.58 (As of May. 23, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Medacta Group Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.58 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Medacta Group's Beneish M-Score or its related term are showing as below:

FRA:6MD' s Beneish M-Score Range Over the Past 10 Years
Min: -2.86   Med: -2.68   Max: -2.21
Current: -2.58

During the past 9 years, the highest Beneish M-Score of Medacta Group was -2.21. The lowest was -2.86. And the median was -2.68.


Medacta Group Beneish M-Score Historical Data

The historical data trend for Medacta Group's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group Beneish M-Score Chart

Medacta Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -2.68 -2.86 -2.21 -2.55 -2.58

Medacta Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.21 - -2.55 - -2.58

Competitive Comparison of Medacta Group's Beneish M-Score

For the Medical Devices subindustry, Medacta Group's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medacta Group's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medacta Group's Beneish M-Score falls into.



Medacta Group Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medacta Group for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0327+0.528 * 1.0254+0.404 * 0.8168+0.892 * 1.1685+0.115 * 1.0667
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9765+4.679 * -0.0399-0.327 * 1.0106
=-2.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was €95.0 Mil.
Revenue was €510.8 Mil.
Gross Profit was €347.8 Mil.
Total Current Assets was €348.5 Mil.
Total Assets was €695.9 Mil.
Property, Plant and Equipment(Net PPE) was €267.3 Mil.
Depreciation, Depletion and Amortization(DDA) was €57.7 Mil.
Selling, General, & Admin. Expense(SGA) was €205.7 Mil.
Total Current Liabilities was €149.4 Mil.
Long-Term Debt & Capital Lease Obligation was €146.9 Mil.
Net Income was €47.4 Mil.
Gross Profit was €0.0 Mil.
Cash Flow from Operations was €75.1 Mil.
Total Receivables was €78.7 Mil.
Revenue was €437.1 Mil.
Gross Profit was €305.3 Mil.
Total Current Assets was €283.7 Mil.
Total Assets was €584.5 Mil.
Property, Plant and Equipment(Net PPE) was €218.5 Mil.
Depreciation, Depletion and Amortization(DDA) was €51.0 Mil.
Selling, General, & Admin. Expense(SGA) was €180.3 Mil.
Total Current Liabilities was €89.1 Mil.
Long-Term Debt & Capital Lease Obligation was €157.3 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(94.996 / 510.778) / (78.72 / 437.122)
=0.185983 / 0.180087
=1.0327

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(305.256 / 437.122) / (347.847 / 510.778)
=0.698331 / 0.681014
=1.0254

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (348.467 + 267.339) / 695.871) / (1 - (283.661 + 218.499) / 584.488)
=0.115057 / 0.140855
=0.8168

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=510.778 / 437.122
=1.1685

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(50.993 / (50.993 + 218.499)) / (57.651 / (57.651 + 267.339))
=0.189219 / 0.177393
=1.0667

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(205.735 / 510.778) / (180.307 / 437.122)
=0.402788 / 0.412487
=0.9765

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((146.945 + 149.421) / 695.871) / ((157.267 + 89.062) / 584.488)
=0.425892 / 0.421444
=1.0106

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(47.362 - 0 - 75.127) / 695.871
=-0.0399

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medacta Group has a M-score of -2.54 suggests that the company is unlikely to be a manipulator.


Medacta Group Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Medacta Group's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Medacta Group (FRA:6MD) Business Description

Traded in Other Exchanges
Address
Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. The company offers solutions for Hip, Knee, Shoulder and Spine.

Medacta Group (FRA:6MD) Headlines

No Headlines